PDGFD and gastric cancer: For instance, the elevated expression of the platelet-derived growth factor D (PDGFD) was proved to be an indicator for a poor prognostic outcome of patients with gastric cancer (GC) (13), and the PDGFD-related immune-gene signature was regarded as a moderator to guide immunotherapy programs.